Company

Akoya Biosciences, Inc.

Headquarters: Marlborough, MA, United States

Employees: 319

CEO: Mr. Brian McKelligon

NASDAQ: AKYA -1.05%

Market Cap

$105.1 Million

USD as of Jan. 1, 2025

Market Cap History

Akoya Biosciences, Inc. market capitalization over time

Evolution of Akoya Biosciences, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Akoya Biosciences, Inc.

Detailed Description

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level to understand disease progression and treatment response. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen, or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. In addition, it offers Proxima, a cloud-based platform designed to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date Dec. 31, 2023
Revenue TTM $96.6 M
EBITDA $-47,142,000
Gross Profit TTM $56.3 M
Profit Margin -65.53%
Operating Margin -33.31%
Quarterly Revenue Growth 24.80%
Financial Reports & Statistics

Stocks & Indices

Akoya Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: AKYA wb_incandescent

Details

Headquarters:

100 Campus Drive

6th Floor

Marlborough, MA 01752

United States

Phone: 855-896-8401

Fax: 855-404-0061